Annotation Detail for TOMM22

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of TOMM22 mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of TOMM22 mRNA | decreases expression | 20106945
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TOMM22 mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TOMM22 mRNA | affects cotreatment|affects expression | 17602206
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.06 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.32 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.32 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.53 | 17620307 18056438 17162532 19061943 16434500 19052882 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.64 | 19183758 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.05 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.13 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.13 | 17978847 16830150 19701751 20514400 16288022 11831363 18506893 16807293 19171122 19208518 16779866 20727157 19539802 18665156 18393292 10672840 18210153 20084675 17761372 20432363 17173139 20524982 16569478 18788625 3084413 16878318 21159647 19519916 20007298 16681979 17138121 19418558 19052882 17162532 19822196 19383236 3581430 19394651 19335982 20101231 16935385 16502159 18978308 17428255 20512989 10737359 18494052 20214788 20935162 16698587 18971187 19107877 16540662 17055752 16328049 18056438 18785209 19919837 18691550 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.58 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.58 | 7505956 2727394 17174075 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
4.05 | 19052882 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.58 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.26 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.20 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.20 | 19107877 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.84 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.08 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.61 | 21071580 20387270 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.83 | 20471113 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.55 | 18785209 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.32 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
3.01 | 18522880 20032147 18407596 18665156 19638242 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.17 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.76 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
11.76 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
11.76 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
11.76 | 18978307 19073162 19255062 19426721 19642983 19833225 21071580 21047994 19294768 19812893 2862719 18644402 21167192 16942905 18648771 12771043 18977376 20452335 19551842 21278145 10737359 19499222 2422723 20137499 15175105 19427195 20118626 18754104 20405173 19638242 19254457 19690152 20501860 12112319 20583210 20434301 9163691 19090486 20492335 15885732 19256749 19850985 20101389 19996281 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.69 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.69 | 18093689 17174075 18775883 18308698 18079962 19539802 19126423 9362446 18544905 16267830 18164116 21159647 19009564 17854601 18253720 17942915 16842330 18282651 19519916 2563599 3124819 19004024 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.46 | 17053015 20869020 20464547 20064080 18520028 18569708 6695378 18816296 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.46 | 20512841 20970405 6695378 21163286 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.50 | 16381670 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.49 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.69 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.33 | 11141357 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.69 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.84 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.83 | 16049721 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.53 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.92 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.79 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.52 | 19755658 10029692 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.40 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.29 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.39 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.95 | 10091137 |